JP2009543799A5 - - Google Patents

Download PDF

Info

Publication number
JP2009543799A5
JP2009543799A5 JP2009519632A JP2009519632A JP2009543799A5 JP 2009543799 A5 JP2009543799 A5 JP 2009543799A5 JP 2009519632 A JP2009519632 A JP 2009519632A JP 2009519632 A JP2009519632 A JP 2009519632A JP 2009543799 A5 JP2009543799 A5 JP 2009543799A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
amount
methoxy
furfuryl
disubstituted purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009519632A
Other languages
English (en)
Japanese (ja)
Other versions
JP5309023B2 (ja
JP2009543799A (ja
Filing date
Publication date
Priority claimed from US11/774,652 external-priority patent/US20080009508A1/en
Application filed filed Critical
Publication of JP2009543799A publication Critical patent/JP2009543799A/ja
Publication of JP2009543799A5 publication Critical patent/JP2009543799A5/ja
Application granted granted Critical
Publication of JP5309023B2 publication Critical patent/JP5309023B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009519632A 2006-07-10 2007-07-10 6,9−二置換プリン誘導体および皮膚を処置するためのその使用 Expired - Fee Related JP5309023B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80687106P 2006-07-10 2006-07-10
US60/806,871 2006-07-10
US11/774,652 2007-07-09
US11/774,652 US20080009508A1 (en) 2006-07-10 2007-07-09 6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
PCT/US2007/073142 WO2008008770A2 (en) 2006-07-10 2007-07-10 6, 9-disubstituted purine derivatives and their use for treating skin

Publications (3)

Publication Number Publication Date
JP2009543799A JP2009543799A (ja) 2009-12-10
JP2009543799A5 true JP2009543799A5 (enExample) 2010-09-09
JP5309023B2 JP5309023B2 (ja) 2013-10-09

Family

ID=38919793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009519632A Expired - Fee Related JP5309023B2 (ja) 2006-07-10 2007-07-10 6,9−二置換プリン誘導体および皮膚を処置するためのその使用

Country Status (16)

Country Link
US (4) US20080009508A1 (enExample)
EP (1) EP2043630B1 (enExample)
JP (1) JP5309023B2 (enExample)
KR (1) KR101478727B1 (enExample)
CN (1) CN101646435B (enExample)
AU (1) AU2007272576B2 (enExample)
BR (1) BRPI0714161A2 (enExample)
CA (1) CA2657516C (enExample)
EA (1) EA015848B1 (enExample)
ES (1) ES2603216T3 (enExample)
IL (1) IL196442A (enExample)
MX (1) MX2009000347A (enExample)
MY (1) MY158100A (enExample)
NO (1) NO20090598L (enExample)
NZ (1) NZ574711A (enExample)
WO (1) WO2008008770A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960397B2 (en) * 2007-12-28 2011-06-14 Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
PE20120493A1 (es) 2009-06-29 2012-05-20 Incyte Corp Pirimidinonas como inhibidores de pi3k
TW201130842A (en) * 2009-12-18 2011-09-16 Incyte Corp Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
US8759359B2 (en) 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
AR081823A1 (es) 2010-04-14 2012-10-24 Incyte Corp DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
EP2395086A1 (en) * 2010-06-09 2011-12-14 Chanel Parfums Beauté Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
ES2459143T3 (es) * 2010-06-09 2014-05-08 Chanel Parfums Beauté Inhibidores de varios microARN para usar en la prevención y/o atenuación del envejecimiento cutáneo y/o para hidratar la piel
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
ES2764848T3 (es) 2010-12-20 2020-06-04 Incyte Holdings Corp N-(1-(fenilo sustituido)etilo)-9H-purina-6-aminas como inhibidores de PI3K
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
KR20230038593A (ko) 2011-09-02 2023-03-20 인사이트 홀딩스 코포레이션 Pi3k 억제제로서 헤테로시클릴아민
US20130072506A1 (en) 2011-09-16 2013-03-21 Lenka ZAHAJSKA 6,8-disubstituted purine compositions
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
CZ306984B6 (cs) 2014-12-15 2017-11-01 Ústav experimentální botaniky AV ČR, v. v. i. 6,8-Disubstituované-9-(heterocyklyl)puriny, přípravky obsahující tyto deriváty a jejich použití v kosmetických a medicínských aplikacích
PH12017501538B1 (en) 2015-02-27 2024-02-14 Incyte Holdings Corp Salts of p13k inhibitor and processes for their preparation
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
CZ307722B6 (cs) * 2015-08-28 2019-03-27 Univerzita PalackĂ©ho v Olomouci Adeninové deriváty a jejich použití
CZ307868B6 (cs) 2017-04-28 2019-07-10 Univerzita PalackĂ©ho v Olomouci Deriváty 9-(2-oxacykloalkyl)-9H-purin-2,6-diaminu, přípravky obsahující tyto deriváty a jejich použití
CN112469418A (zh) 2018-06-01 2021-03-09 因赛特公司 治疗pi3k相关病症的给药方案
WO2022012702A1 (en) 2020-07-13 2022-01-20 Univerzita Palackeho V Olomouci Nitrogen heterocyclic cytokinin derivatives, compositions containing these derivatives and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371089A (en) * 1987-02-26 1994-12-06 Senetek, Plc Method and composition for ameliorating the adverse effects of aging
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
WO2004037159A2 (en) * 2002-10-23 2004-05-06 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
EP2145888A1 (en) * 2003-09-18 2010-01-20 Conforma Therapeutics Corporation Deazapurine derivatives as HSP90-Inhibitors
JP2009500394A (ja) * 2005-07-08 2009-01-08 ザ プロクター アンド ギャンブル カンパニー パーソナルケア組成物及び哺乳類の皮膚と毛髪を美化する方法

Similar Documents

Publication Publication Date Title
JP2009543799A5 (enExample)
RU2335493C2 (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
JP2012508734A5 (enExample)
SG10201909122QA (en) Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
JP2010521514A5 (enExample)
ES2611483T3 (es) Agente terapéutico para enfermedad inflamatoria intestinal
JP2013525444A5 (enExample)
JP2012184234A5 (enExample)
EA201490852A1 (ru) Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
JP2014500861A5 (enExample)
JP2008501000A5 (enExample)
JP2013509429A5 (enExample)
JP2013519645A5 (enExample)
JP2010513224A5 (enExample)
RU2012123372A (ru) Гетероциклические модуляторы транспортеров атф-связывающей кассеты
JP2013541514A5 (enExample)
JP2010155827A5 (enExample)
JP2013528655A5 (enExample)
JP2011527333A5 (enExample)
JP2008500999A5 (enExample)
JP2010524947A5 (enExample)
JP2018537513A5 (enExample)
JP2011046708A5 (enExample)
JP2011246469A5 (enExample)
JP2013510169A5 (enExample)